Sales & Marketing AI and pharma launch - Within3’s Jason Smith Jason Smith, CTO of AI and analytics at Within3, discusses data-fuelled agile launches and smarter decision-making.
Market Access Sponsored From first approval to lasting value: What sets successful e... Approval may validate the science, but it does not secure commercial success. That outcome is determined by the decisions made before launch.
Market Access The new commercialisation playbook: What BIO 2026 taught eme... BIO International focused on how emerging biotech companies should approach their first product launch outside the United States, typically in Europe.
Market Access Why global pharmaceutical reforms are quietly redirecting ra... Publication of the 2026 Pharma Package by the Council of the EU represents the most significant reform of EU pharmaceutical legislation in over 20 yrs
Digital The cliff was never the crisis: Pharma’s strategy problem The patent cliff isn't the problem. It's the symptom.
Sales & Marketing Sponsored Pushing through barriers to commercial launch success, with ... In this sponsored pharmaphorum podcast, Amanjeet Singh Saluja, a Principal at Axtria, discusses the current state of affairs in launch success.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
